Literature DB >> 30732978

Impact of colonizing organism in the respiratory tract on the incidence, duration, and time between subsequent hospitalizations among patients with cystic fibrosis.

Klaudia Cios1, Bevin Cohen2, Lynne M Quittell3, Jianfang Liu4, Elaine L Larson5.   

Abstract

BACKGROUND: This study aimed to examine the association between colonizing respiratory tract organism and frequency, duration, and time between subsequent hospitalizations among hospitalized patients with cystic fibrosis (CF).
METHODS: This retrospective cohort study of 312 CF patients from 2 New York City hospitals (2006-2016) examined the effects of colonization with Pseudomonas aeruginosa, methicillin-susceptible Staphylococcus aureus (MSSA) or methicillin-resistant S aureus (MRSA), co-colonization on incidence of hospitalization, time to next hospitalization, and total length of stay (LOS).
RESULTS: Annual rate of subsequent hospitalizations was highest in patients with P aeruginosa: adjusted incidence rate ratios (aIRRs) were 2.75 (95% confidence interval [CI], 1.72-4.41) for P aeruginosa versus MSSA, 2.57 (95% CI, 1.52-4.31) for co-colonization versus MSSA, and 1.77 (95% CI, 1.04-3.01) for P aeruginosa versus MRSA. Time to readmission was shortest for P aeruginosa: aIRRs were 1.75 (95% CI, 1.05-2.94) for MRSA versus P aeruginosa, 1.64 (95% CI, 1.03-2.59) for MSSA versus P aeruginosa, and 1.61 (95% CI, 1.04-2.47) for co-colonization versus P aeruginosa. LOS was longest for P aeruginosa: aIRRs were 3.41 (95% CI, 2.19-5.32) for P aeruginosa versus MSSA, 1.66 (95% CI, 1.01-2.75) for co-colonization versus MSSA, 2.50 (95% CI, 1.58-3.93) for P aeruginosa versus MRSA, and 2.05 (95% CI, 1.32-3.18) for P aeruginosa versus co-colonization.
CONCLUSIONS: CF patients with P aeruginosa alone experienced more hospitalizations, longer LOS, and shorter time to readmission versus patients with S aureus or both organisms.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Hospital readmission; Methicillin-resistant Staphylococcus aureus; Methicillin-susceptible Staphylococcus aureus; Pseudomonas aeruginosa

Mesh:

Substances:

Year:  2019        PMID: 30732978     DOI: 10.1016/j.ajic.2018.12.021

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  2 in total

1.  Mixed Populations and Co-Infection: Pseudomonas aeruginosa and Staphylococcus aureus.

Authors:  Laura Camus; Paul Briaud; François Vandenesch; Anne Doléans-Jordheim; Karen Moreau
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Impact of Coexistence Phenotype Between Staphylococcus aureus and Pseudomonas aeruginosa Isolates on Clinical Outcomes Among Cystic Fibrosis Patients.

Authors:  Paul Briaud; Sylvère Bastien; Laura Camus; Marie Boyadjian; Philippe Reix; Catherine Mainguy; François Vandenesch; Anne Doléans-Jordheim; Karen Moreau
Journal:  Front Cell Infect Microbiol       Date:  2020-06-03       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.